PharVision Advisers’s Obsidian Energy OBE Stock Holding History

PharVision Advisers’s Portfolio OBE Stock Details OBE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-28,630	Closed	-$187K	–	912
2025 Q3	$187K	Buy	+28,630	New	+$170K	0.11%	530

Other funds holding OBE

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PharVision Advisers's OBE Position: Q4 2025 in Review

PharVision Advisers sold out of Obsidian Energy (OBE) in Q4 2025, closing a stake of 28,630 shares — an estimated $187K sold.

PharVision Advisers first reported a position in OBE in Q3 2025 and held it in 1 quarter. The position peaked at $187K in Q3 2025. 89 funds tracked by Wall St. Rank hold OBE as of Q4 2025.

PharVision Advisers reported no remaining Obsidian Energy position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 28,630 Obsidian Energy shares in Q4 2025, an estimated $187K.
PharVision Advisers first reported a position in Obsidian Energy in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Obsidian Energy position peaked at $187K in Q3 2025.
89 funds tracked by Wall St. Rank held Obsidian Energy as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.